The global anticoagulant reversal drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Anticoagulant reversal drugs come in various drug classes such as prothrombin complex concentrates, coagulation factors, monoclonal antibodies, phytonadione, and other drug classes. In addition to this, the high demand for these drugs from various end-users such as hospitals, pharmacies, retail pharmacies, and others is primarily contributing to the global market growth.

The other key factors contributing to the market growth include a surge in the global prevalence of multiple cardiovascular indications, the increase in intracranial and gastrointestinal haemorrhages, atrial fibrillation, and the constantly rising geriatric population. The mortalities registered due to these diseases too is quite high. As per the World Health Organization, each year an estimated 17.9 million people die due to cardiovascular diseases around the globe. This further indicates the share of 35% of the global mortalities. Additionally, 85% of these cardiovascular disease mortalities are registered due to heart attacks and strokes.

Some key players operating in the market include Pfizer Inc., Boehringer Ingelheim GmbH, CSL Behring Limited, Portola Pharmaceuticals Inc., and Octapharma AG, among others. These players are eyeing to strengthen their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Pfizer Inc., Boehringer Ingelheim GmbH, CSL Behring Limited, Portola Pharmaceuticals Inc., and Octapharma AG, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Anticoagulant Reversal Drugs Market by Segments 

By Drug Class 

• Prothrombin Complex Concentrates

• Coagulation Factors

• Monoclonal Antibodies

• Phytonadione

• Others 

By End-User 

• Hospital Pharmacies

• Retail Pharmacies

• Others

Global Anticoagulant Reversal Drugs Market by Region